DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,640
+1,510 (9.98%)
At close: Feb 27, 2026
54.36%
Market Cap 291.48B
Revenue (ttm) 149.47B
Net Income (ttm) 39.73M
Shares Out 17.52M
EPS (ttm) 2.27
PE Ratio 7,337.11
Forward PE n/a
Dividend 150.00 (0.90%)
Ex-Dividend Date Dec 29, 2025
Volume 1,714,109
Average Volume 179,788
Open 18,470
Previous Close 15,130
Day's Range 16,200 - 18,620
52-Week Range 10,330 - 24,900
Beta -0.30
RSI 58.81
Earnings Date Feb 6, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.